Preretinal hemorrhage as a presenting sign of idiopathic macular telangiectasia type 2

被引:3
|
作者
Osher, James M. [1 ,2 ]
Sisk, Robert A. [1 ,2 ]
Petersen, Michael R. [2 ]
机构
[1] Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH USA
[2] Cincinnati Eye Inst, 1945 CEI Dr, Cincinnati, OH 45242 USA
来源
CLINICAL OPHTHALMOLOGY | 2015年 / 9卷
关键词
idiopathic macular telangiectasia; juxtafoveal telangiectasia; preretinal hemorrhage; Valsalva retinopathy;
D O I
10.2147/OPTH.S83335
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
We report three cases of idiopathic macular telangiectasia type 2 with temporally decentered preretinal hemorrhage as the presenting sign. The preretinal blood obscured the telangiectatic vessels such that the diagnosis was only evident by fluorescein angiography of the fellow eyes, which had near-normal vision. The preretinal hemorrhage was associated with Valsalva maneuver in one patient and with type 3 subretinal neovascularization in one patient. We speculate that the vascular dilations in idiopathic macular telangiectasia type 2 may increase patients' susceptibility to rupture and hemorrhage with increased venous pressure.
引用
收藏
页码:1417 / 1420
页数:4
相关论文
共 50 条
  • [31] THE INCIDENCE OF IDIOPATHIC PRERETINAL MACULAR GLIOSIS
    PEARLSTONE, AD
    ANNALS OF OPHTHALMOLOGY, 1985, 17 (06): : 378 - 380
  • [32] Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia
    Issa, Peter Charbel
    Helb, Hans-Martin
    Holz, Frank G.
    Scholl, Hendrik P. N.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (01) : 169 - 175
  • [33] Treatment of proliferative idiopathic macular telangiectasia Type 2 with intravitreal bevacizumab
    Sandhu, Ranjit
    Hamilton, Robin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [34] Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia
    Issa, Peter Charbel
    Berendschot, Tos T. J. M.
    Staurenghi, Giovanni
    Holz, Frank G.
    Scholl, Hendrik P. N.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (03) : 1172 - 1177
  • [35] Long-term course in type 2 idiopathic macular telangiectasia
    Tobias Meyer-ter-Vehn
    Sina Herzog
    Marc Schargus
    Winfried Göbel
    Rainer Guthoff
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2013, 251 : 2513 - 2520
  • [36] Long-term course in type 2 idiopathic macular telangiectasia
    Meyer-ter-Vehn, Tobias
    Herzog, Sina
    Schargus, Marc
    Goebel, Winfried
    Guthoff, Rainer
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (11) : 2513 - 2520
  • [37] Characteristics of pigmented lesions in type 2 idiopathic macular telangiectasia (MacTel).
    Leung, Irene
    Sallo, Ferenc B.
    Pauleikhoff, Daniel
    Bird, Alan C.
    Clemons, Traci E.
    Peto, Tunde
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [38] CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY
    Matet, Alexandre
    Yzer, Suzanne
    Chew, Emily Y.
    Daruich, Alejandra
    Behar-Cohen, Francine
    Spaide, Richard F.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 : S67 - S78
  • [39] The Prevalence of Type 2 Idiopathic Macular Telangiectasia in Two African Populations
    Sallo, Ferenc B.
    Leung, Irene
    Mathenge, Wanjiku
    Kyari, Fatima
    Kuper, Hannah
    Gilbert, Clare E.
    Bird, Alan C.
    Peto, Tunde
    OPHTHALMIC EPIDEMIOLOGY, 2012, 19 (04) : 185 - 189
  • [40] Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia
    Wolf-Schnurrbusch, Ute E. K.
    Leung, Irene
    Sallo, Ferenc B.
    Clemons, Traci E.
    Chew, Emily Y.
    Bird, Alan C.
    Peto, Tunde
    OPHTHALMIC RESEARCH, 2018, 60 (01) : 38 - 42